Patient Guides: ESMO Patient Guides Compilation (Belgium): Difference between revisions
No edit summary |
No edit summary |
||
| Line 4: | Line 4: | ||
'''Primary purpose:''' To translate complex medical language into understandable information for patients. [https://www.esmo.org/for-patients/patient-guides Click here to learn more]. | '''Primary purpose:''' To translate complex medical language into understandable information for patients. [https://www.esmo.org/for-patients/patient-guides Click here to learn more]. | ||
'''Type of information:''' Information on each guide varies for each cancer type. Generally, guides provide definitions, explanations of causes, [[availableVariable::diagnosis]], [[availableVariable::medical procedures|treatment]], treatment options, care after treatment, among others. https://www.esmo.org/for-patients/patient-guides/patient-guides-by-language/cancer-patient-guides-in-dutch Click here to learn more]. | '''Type of information:''' Information on each guide varies for each cancer type. Generally, guides provide definitions, explanations of causes, [[availableVariable::diagnosis]], [[availableVariable::medical procedures|treatment]], treatment options, care after treatment, among others. [https://www.esmo.org/for-patients/patient-guides/patient-guides-by-language/cancer-patient-guides-in-dutch Click here to learn more]. | ||
'''Cancer areas of interest:''' [[hasCancerType::C40-C41: Bone cancers]]; [[hasCancerType::C15-C26: Digestive system cancers]]; [[hasCancerType::C51-C58: Female genitalia cancer]]; [[hasCancerType::C81-C96: Cancers of the blood and immune system]]; [[hasCancerType::C69-C72: Eye and brain cancer]]; [[hasCancerType::C00-C14: Mouth/throat cancers]]; [[hasCancerType::C45-C49: Soft tissue cancer]]. Side Effects of Immunotherapy and Its Management; AML; Bone Sarcomas; Colorectal Cancer; Endometrial Cancer; Follicular Lymphoma; Glioma; Head and Neck Cancers; CML; Stomach Cancer; Soft Tissue Sarcomas. [https://www.esmo.org/for-patients/patient-guides/patient-guides-by-language/cancer-patient-guides-in-dutch Click here to learn more]. | '''Cancer areas of interest:''' [[hasCancerType::C40-C41: Bone cancers]]; [[hasCancerType::C15-C26: Digestive system cancers]]; [[hasCancerType::C51-C58: Female genitalia cancer]]; [[hasCancerType::C81-C96: Cancers of the blood and immune system]]; [[hasCancerType::C69-C72: Eye and brain cancer]]; [[hasCancerType::C00-C14: Mouth/throat cancers]]; [[hasCancerType::C45-C49: Soft tissue cancer]]. Side Effects of Immunotherapy and Its Management; AML; Bone Sarcomas; Colorectal Cancer; Endometrial Cancer; Follicular Lymphoma; Glioma; Head and Neck Cancers; CML; Stomach Cancer; Soft Tissue Sarcomas. [https://www.esmo.org/for-patients/patient-guides/patient-guides-by-language/cancer-patient-guides-in-dutch Click here to learn more]. | ||
'''Access to information:''' [https://www.esmo.org/for-patients/patient-guides/patient-guides-by-language/cancer-patient-guides-in-dutch Click here to access]. | '''Access to information:''' [https://www.esmo.org/for-patients/patient-guides/patient-guides-by-language/cancer-patient-guides-in-dutch Click here to access]. | ||
Revision as of 19:41, 25 June 2024
Go back to Belgium page
Primary purpose: To translate complex medical language into understandable information for patients. Click here to learn more.
Type of information: Information on each guide varies for each cancer type. Generally, guides provide definitions, explanations of causes, diagnosis, treatment, treatment options, care after treatment, among others. Click here to learn more.
Cancer areas of interest: C40-C41: Bone cancers; C15-C26: Digestive system cancers; C51-C58: Female genitalia cancer; C81-C96: Cancers of the blood and immune system; C69-C72: Eye and brain cancer; C00-C14: Mouth/throat cancers; C45-C49: Soft tissue cancer. Side Effects of Immunotherapy and Its Management; AML; Bone Sarcomas; Colorectal Cancer; Endometrial Cancer; Follicular Lymphoma; Glioma; Head and Neck Cancers; CML; Stomach Cancer; Soft Tissue Sarcomas. Click here to learn more.
Access to information: Click here to access.
